Hypha Labs Statistics
Total Valuation
Hypha Labs has a market cap or net worth of 5.02 million. The enterprise value is 7.06 million.
| Market Cap | 5.02M |
| Enterprise Value | 7.06M |
Important Dates
The next estimated earnings date is Friday, May 15, 2026.
| Earnings Date | May 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Hypha Labs has 162.52 million shares outstanding. The number of shares has increased by 28.17% in one year.
| Current Share Class | 162.52M |
| Shares Outstanding | 162.52M |
| Shares Change (YoY) | +28.17% |
| Shares Change (QoQ) | +2.42% |
| Owned by Insiders (%) | 20.50% |
| Owned by Institutions (%) | n/a |
| Float | 129.20M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -2.14 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.09 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -12.76 |
Financial Position
The company has a current ratio of 0.24
| Current Ratio | 0.24 |
| Quick Ratio | 0.03 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -3.16 |
| Interest Coverage | -15.27 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -406.23% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 227.42% |
| Weighted Average Cost of Capital (WACC) | 9.98% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -456,780 |
| Employee Count | 5 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.86% in the last 52 weeks. The beta is 1.28, so Hypha Labs's price volatility has been higher than the market average.
| Beta (5Y) | 1.28 |
| 52-Week Price Change | -12.86% |
| 50-Day Moving Average | 0.04 |
| 200-Day Moving Average | 0.03 |
| Relative Strength Index (RSI) | 45.74 |
| Average Volume (20 Days) | 84,483 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.17 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -2.11M |
| Pretax Income | -2.28M |
| Net Income | -2.28M |
| EBITDA | -2.10M |
| EBIT | -2.11M |
| Earnings Per Share (EPS) | -0.02 |
Balance Sheet
The company has 42,854 in cash and 1.75 million in debt, giving a net cash position of -1.71 million or -0.01 per share.
| Cash & Cash Equivalents | 42,854 |
| Total Debt | 1.75M |
| Net Cash | -1.71M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | -2.35M |
| Book Value Per Share | -0.02 |
| Working Capital | -1.01M |
Cash Flow
In the last 12 months, operating cash flow was -522,271 and capital expenditures -31,235, giving a free cash flow of -553,506.
| Operating Cash Flow | -522,271 |
| Capital Expenditures | -31,235 |
| Free Cash Flow | -553,506 |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Hypha Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -28.17% |
| Shareholder Yield | -28.17% |
| Earnings Yield | -45.48% |
| FCF Yield | -11.02% |
Stock Splits
The last stock split was on May 27, 2015. It was a reverse split with a ratio of 0.1.
| Last Split Date | May 27, 2015 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |